Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models.

Authors: Nicole Pinto, Stephenie D Prokopec, Frederick Vizeacoumar, Karlee Searle, Matthew Lowerison, Kara M Ruicci, John Yoo, Kevin Fung, Danielle MacNeil, Jim C Lacefield, Hon S Leong, Joe S Mymryk, John W Barrett, Alessandro Datti, Paul C Boutros, Anthony C Nichols

Source: PLoS ONE, Vol 13, Iss 11, p e0207152 (2018)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC6231667?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/791914e6779c49f59f8e351657650e5c